000 01394 a2200397 4500
005 20250515044835.0
264 0 _c20070508
008 200705s 0 0 eng d
022 _a0361-8609
024 7 _a10.1002/ajh.20773
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOfran, Yishay
245 0 0 _aDifferentiation syndrome with lethal lung injury after arsenic trioxide treatment for myelodysplastic syndrome.
_h[electronic resource]
260 _bAmerican journal of hematology
_cApr 2007
300 _a332-3 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aArsenic Trioxide
650 0 4 _aArsenicals
_xadverse effects
650 0 4 _aCell Differentiation
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMyelodysplastic Syndromes
_xdrug therapy
650 0 4 _aOxides
_xadverse effects
650 0 4 _aPulmonary Alveoli
_xdrug effects
650 0 4 _aRespiratory Distress Syndrome
_xchemically induced
650 0 4 _aSyndrome
700 1 _aAvivi, Irit
700 1 _aGesundheit, Benjamin
700 1 _aOr, Reuven
700 1 _aRowe, Jacob M
700 1 _aZuckerman, Tsila
773 0 _tAmerican journal of hematology
_gvol. 82
_gno. 4
_gp. 332-3
856 4 0 _uhttps://doi.org/10.1002/ajh.20773
_zAvailable from publisher's website
999 _c16654250
_d16654250